TPY Capital

AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.

UNIPaaS is a payment solution that enables digital platforms and marketplaces to own, manage, and monetize from financial services. Digital marketplaces and B2B platforms can now own their payment experience and control their funds' flow. They are transforming how businesses integrate and handle payments, reducing financial operations costs, and accelerating the implementation of new growth engines powered by payments and financial services. By monetizing these activities and providing these new services to customers in the right context, digital platforms can effectively increase stickiness, and lifetime value, and generate additional revenues. UNIPaaS was founded in 2020 and is based in Israel.

AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.

Founded in 2019, H2Pro develops innovative water-splitting technology for producing hydrogen fuel. Its proprietary E-TAC method decouples hydrogen and oxygen evolution reactions, enabling efficient and sustainable green hydrogen production.

AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.

Founded in 2006, Clicktale is a global leader in Experience Analytics. It offers a cloud-based platform that tracks and analyzes digital customer experiences, enabling businesses to understand visitor behavior, optimize websites, and improve conversion rates. Serving clients worldwide across various sectors such as e-commerce, finance, media, and travel, Clicktale's solutions include session playback, heatmaps, form analytics, and customizable conversion funnels.

Enzymotec Ltd. is a biotechnology company based in Migdal Haemeq, Israel, specializing in the development, manufacture, and marketing of bio-functional lipid ingredients and medical foods. The company operates primarily in North America, the European Union, Australia, New Zealand, Asia, and Israel. Enzymotec's Nutrition segment focuses on lipid-based nutritional ingredients, including phospholipids that mimic human breast milk fat for infant formulas, soy-derived phosphatidylserine products aimed at enhancing cognitive performance, and krill oil rich in omega-3 fatty acids. Its offerings also extend to supplements designed for memory improvement in various age groups. The VAYA Pharma segment develops lipid-based medical foods targeting cardiovascular and neurological health, including products for managing attention deficit-hyperactivity disorder and early memory impairment. Founded in 1998, Enzymotec has positioned itself as a provider of advanced nutritional and medical solutions that address health needs across the human life cycle.